KLG Stock +78.58% In 3 Months Since We Picked KLG Stock +78.58% In 3 Months Since We Picked Unlock All Top Buy Picks

Range Low Price High Price Comment
30 days $0.500 $0.720 Friday, 26th Apr 2024 ADXS stock ended at $0.555. This is 0.91% more than the trading day before Thursday, 25th Apr 2024. During the day the stock fluctuated 0.91% from a day low at $0.550 to a day high of $0.555.
90 days $0.500 $1.49
52 weeks $0.500 $1.95

Historical Advaxis prices

Date Open High Low Close Volume
Apr 12, 2016 $140.85 $140.85 $140.85 $140.85 53 927
Apr 11, 2016 $137.25 $137.25 $137.25 $137.25 41 570
Apr 08, 2016 $141.45 $141.45 $141.45 $141.45 41 505
Apr 07, 2016 $143.55 $143.55 $143.55 $143.55 67 312
Apr 06, 2016 $149.85 $149.85 $149.85 $149.85 75 429
Apr 05, 2016 $139.20 $139.20 $139.20 $139.20 37 792
Apr 04, 2016 $139.20 $139.20 $139.20 $139.20 47 437
Apr 01, 2016 $138.90 $138.90 $138.90 $138.90 51 729
Mar 31, 2016 $135.45 $135.45 $135.45 $135.45 64 059
Mar 30, 2016 $132.15 $132.15 $132.15 $132.15 59 065
Mar 29, 2016 $130.50 $130.50 $130.50 $130.50 48 900
Mar 28, 2016 $125.25 $125.25 $125.25 $125.25 43 753
Mar 24, 2016 $131.10 $131.10 $131.10 $131.10 61 453
Mar 23, 2016 $127.65 $127.65 $127.65 $127.65 112 373
Mar 22, 2016 $147.45 $147.45 $147.45 $147.45 126 567
Mar 21, 2016 $138.75 $138.75 $138.75 $138.75 124 747
Mar 18, 2016 $123.60 $123.60 $123.60 $123.60 159 360
Mar 17, 2016 $121.50 $121.50 $121.50 $121.50 66 807
Mar 16, 2016 $125.70 $125.70 $125.70 $125.70 45 800
Mar 15, 2016 $123.90 $123.90 $123.90 $123.90 45 747
Mar 14, 2016 $128.10 $128.10 $128.10 $128.10 44 533
Mar 11, 2016 $122.55 $122.55 $122.55 $122.55 62 793
Mar 10, 2016 $117.30 $117.30 $117.30 $117.30 61 553
Mar 09, 2016 $129.45 $129.45 $129.45 $129.45 62 487
Mar 08, 2016 $128.40 $128.40 $128.40 $128.40 78 253
Click to get the best stock tips daily for free!

About Advaxis

Advaxis Advaxis, Inc., a clinical-stage biotechnology company, focuses on the discovery, development, and commercialization of proprietary Listeria monocytogenes (Lm) technology antigen delivery products in the United States. The company is developing ADXS-PSA, which is in Phase 2 clinical trials for the treatment of metastatic prostate cancer; ADXS-503 that is in Phase 1/2 clinical trials for the treatment of non-small cell lung cancer; and ADXS-504 for... ADXS Profile

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE

ROCKIT